[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL133196A0 - Gastroretentive controlled release pharmaceutical dosage forms - Google Patents

Gastroretentive controlled release pharmaceutical dosage forms

Info

Publication number
IL133196A0
IL133196A0 IL13319699A IL13319699A IL133196A0 IL 133196 A0 IL133196 A0 IL 133196A0 IL 13319699 A IL13319699 A IL 13319699A IL 13319699 A IL13319699 A IL 13319699A IL 133196 A0 IL133196 A0 IL 133196A0
Authority
IL
Israel
Prior art keywords
polymers
controlled release
dosage forms
pharmaceutical dosage
release pharmaceutical
Prior art date
Application number
IL13319699A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL13319699A priority Critical patent/IL133196A0/xx
Priority to AT00978993T priority patent/ATE300286T1/de
Priority to PCT/IL2000/000774 priority patent/WO2001037812A2/en
Priority to ES00978993T priority patent/ES2243327T3/es
Priority to EP00978993A priority patent/EP1235557B1/de
Priority to CA002392361A priority patent/CA2392361C/en
Priority to AU16477/01A priority patent/AU783062B2/en
Priority to RU2002114348/15A priority patent/RU2002114348A/ru
Priority to DE60021604T priority patent/DE60021604T2/de
Priority to IL14985300A priority patent/IL149853A0/xx
Priority to JP2001539427A priority patent/JP4679020B2/ja
Publication of IL133196A0 publication Critical patent/IL133196A0/xx
Priority to IL149853A priority patent/IL149853A/en
Priority to ZA200204268A priority patent/ZA200204268B/xx
Priority to US10/157,325 priority patent/US6685962B2/en
Priority to AU2005256098A priority patent/AU2005256098A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13319699A 1999-11-29 1999-11-29 Gastroretentive controlled release pharmaceutical dosage forms IL133196A0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IL13319699A IL133196A0 (en) 1999-11-29 1999-11-29 Gastroretentive controlled release pharmaceutical dosage forms
RU2002114348/15A RU2002114348A (ru) 1999-11-29 2000-11-20 Удерживаемые в желудке фармацевтические лекарственные формы с контролируемым высвобождением
DE60021604T DE60021604T2 (de) 1999-11-29 2000-11-20 Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben
ES00978993T ES2243327T3 (es) 1999-11-29 2000-11-20 Formas de dosificacion farmaceuticas de liberacion gastrorretentiva controlada.
EP00978993A EP1235557B1 (de) 1999-11-29 2000-11-20 Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben
CA002392361A CA2392361C (en) 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms
AU16477/01A AU783062B2 (en) 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms
AT00978993T ATE300286T1 (de) 1999-11-29 2000-11-20 Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben
PCT/IL2000/000774 WO2001037812A2 (en) 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms
IL14985300A IL149853A0 (en) 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms
JP2001539427A JP4679020B2 (ja) 1999-11-29 2000-11-20 胃内滞留性制御放出医薬剤形
IL149853A IL149853A (en) 1999-11-29 2002-05-26 Gastroretentive controlled release pharmaceutical dosage forms
ZA200204268A ZA200204268B (en) 1999-11-29 2002-05-28 Gastroretentive controlled release pharmaceutical dosage forms.
US10/157,325 US6685962B2 (en) 1999-11-29 2002-05-29 Gastroretentive controlled release pharmaceutical dosage forms
AU2005256098A AU2005256098A1 (en) 1999-11-29 2005-12-22 Gastroretentive controlled release pharmaceutical dosage forms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13319699A IL133196A0 (en) 1999-11-29 1999-11-29 Gastroretentive controlled release pharmaceutical dosage forms

Publications (1)

Publication Number Publication Date
IL133196A0 true IL133196A0 (en) 2001-03-19

Family

ID=11073546

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13319699A IL133196A0 (en) 1999-11-29 1999-11-29 Gastroretentive controlled release pharmaceutical dosage forms
IL149853A IL149853A (en) 1999-11-29 2002-05-26 Gastroretentive controlled release pharmaceutical dosage forms

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149853A IL149853A (en) 1999-11-29 2002-05-26 Gastroretentive controlled release pharmaceutical dosage forms

Country Status (12)

Country Link
US (1) US6685962B2 (de)
EP (1) EP1235557B1 (de)
JP (1) JP4679020B2 (de)
AT (1) ATE300286T1 (de)
AU (1) AU783062B2 (de)
CA (1) CA2392361C (de)
DE (1) DE60021604T2 (de)
ES (1) ES2243327T3 (de)
IL (2) IL133196A0 (de)
RU (1) RU2002114348A (de)
WO (1) WO2001037812A2 (de)
ZA (1) ZA200204268B (de)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219186A1 (en) * 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
TWI312285B (en) * 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
WO2004056343A1 (en) 2002-12-19 2004-07-08 Polymorfix, Inc. Ingestible formulations for transient, noninvasive reduction of gastric volume
US7554452B2 (en) * 2003-07-18 2009-06-30 Cary Cole Ingestible tracking and locating device
EP1660153A2 (de) * 2003-09-04 2006-05-31 The United States of America as represented by the Department of Veterans Affairs Hydrogel-nanokomposite für ophthalmische anwendungen
US20070122480A1 (en) * 2003-09-29 2007-05-31 Cj Corporation Sustained release formulations
US20050201974A1 (en) * 2003-12-09 2005-09-15 Spherics, Inc. Bioadhesive polymers with catechol functionality
US20080089933A1 (en) * 2006-10-16 2008-04-17 Amir Alon Device and method for reducing calorie intake
US20050196355A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Film products having controlled disintegration properties
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
DE602005025755D1 (de) 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
BRPI0518396A2 (pt) * 2004-12-27 2008-11-18 Eisai R&D Man Co Ltd mÉtodo para estabilizaÇço de droga anti-demÊncia
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
IL166183A0 (en) * 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
KR100822519B1 (ko) * 2005-02-15 2008-04-16 주식회사종근당 위장 내에서 제어방출되는 단일 매트릭스 정제
WO2007041079A2 (en) * 2005-09-30 2007-04-12 Alza Corporation Banded controlled release nanoparticle active agent formulation dosage forms and methods
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
US8298574B2 (en) 2006-01-18 2012-10-30 Intec Pharma Ltd. Method and apparatus for forming delivery devices for oral intake of an agent
US20090304768A1 (en) * 2006-02-15 2009-12-10 Intec Pharma Ltd Gastro-Retentive System for the Delivery of Macromolecules
US20100226855A1 (en) * 2006-03-02 2010-09-09 Spherics, Inc. Rate-Controlled Oral Dosage Formulations
WO2008030830A2 (en) * 2006-09-08 2008-03-13 Drugtech Corporation Sustained-release composition and method of use thereof
NZ578204A (en) 2006-12-22 2012-05-25 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
WO2008115597A2 (en) * 2007-03-21 2008-09-25 Cytologic, Inc. Cytokine muteins and methods for enhancing immune responses in mammals
FI2192946T3 (fi) 2007-09-25 2022-11-30 Elimistön sisäinen laite, jossa on virtuaalinen dipolisignaalinvahvistus
EP2219621B1 (de) 2007-11-12 2013-12-25 Pharmaceutics International, Inc. Trimolekulare komplexe und ihre verwendung in arzneiabgabesystemen
US8771730B2 (en) * 2008-04-18 2014-07-08 Intec Pharma Ltd. Carbidopa/Levodopa gastroretentive drug delivery
JP5074583B2 (ja) * 2008-05-08 2012-11-14 パナソニック株式会社 不揮発性記憶素子の製造方法、および不揮発性記憶装置の製造方法
US8287902B2 (en) * 2008-07-23 2012-10-16 Rainbow Medical Ltd. Enhanced-diffusion capsule
KR20110116004A (ko) * 2008-12-04 2011-10-24 인텍 파마 리미티드 잘레플론 위장체류 약물 전달 시스템
EA201101524A1 (ru) 2009-04-20 2012-07-30 Элселикс Терапьютикс, Инк. Способ и композиция для лечения состояния, связанного с хемосенсорным рецептором
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US20100286628A1 (en) * 2009-05-07 2010-11-11 Rainbow Medical Ltd Gastric anchor
US20110066175A1 (en) * 2009-05-07 2011-03-17 Rainbow Medical Ltd. Gastric anchor
US8414559B2 (en) * 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
EP2490677A2 (de) * 2009-10-19 2012-08-29 Intec Pharma Ltd. Neue gastroretentive dosierungsformen schwach löslicher arzneimittel
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
WO2011057133A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Fragmented hydrogels
WO2011073968A1 (en) * 2009-12-18 2011-06-23 Vysera Biomedical Limited A drug delivery system
JP5753187B2 (ja) 2009-12-18 2015-07-22 ヴィセラ・バイオメディカル・リミテッド 医用生体材料
EP2544666A2 (de) 2010-03-09 2013-01-16 Council of Scientific and Industrial Research Gastroretentive retard-zusammensetzung eines therapeutikums
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
BR112013009635A2 (pt) 2010-10-19 2016-07-12 Elcelyx Therapeutics Inc terapias à base de ligante de receptor quimiossensorial
MX2013007884A (es) 2011-01-07 2013-09-13 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
US8722066B2 (en) 2011-03-29 2014-05-13 Primigenia, LLC Devices and methods for weight control and weight loss
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
WO2014039951A1 (en) 2012-09-10 2014-03-13 Novartis Ag Enteral pharmaceutical compositions
EP2988729A1 (de) * 2013-04-25 2016-03-02 Sun Pharmaceutical Industries Limited Magensaftresistente pharmazeutische feste orale darreichungsform von nilotinib
WO2014197744A1 (en) 2013-06-05 2014-12-11 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
CN105828809B (zh) 2013-12-20 2019-10-29 费森尤斯卡比德国有限公司 包含脂质和活性药剂的具有聚合物涂层的微胶囊
CA2949372C (en) 2014-06-02 2023-08-22 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
DK3725357T3 (da) 2014-06-11 2024-12-09 Massachusetts Inst Technology Opholdsstrukturer og relaterede fremgangsmåder
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
US9492396B2 (en) 2014-07-15 2016-11-15 Yossi Gross Enhanced drug delivery pill
CN106236715B (zh) * 2015-06-03 2021-05-07 南京三迭纪医药科技有限公司 药品剂型及其使用
KR20180014778A (ko) 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
MA42196A (fr) 2015-06-17 2018-04-25 Biogen Ma Inc Particules de fumarate de diméthyle et leurs compositions pharmaceutiques
JP7085473B2 (ja) 2015-10-23 2022-06-16 リンドラ セラピューティクス， インコーポレイティド 治療薬の持続放出用の胃内滞留システム及びその使用方法
US11129798B2 (en) 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
US11478427B2 (en) * 2015-10-26 2022-10-25 Aron H. Blaesi Dosage form comprising structural framework of two-dimensional elements
EP3368010A4 (de) * 2015-10-26 2019-04-10 Blaesi, Aron H. Feste dosierungsform für sofortige wirkstofffreisetzung sowie vorrichtung und verfahren zur herstellung davon
AU2016365321A1 (en) * 2015-12-01 2018-06-21 Clexio Biosciences Ltd. Gastric retentive devices
JP2018537201A (ja) * 2015-12-02 2018-12-20 クレキシオ バイオサイエンシーズ エルティーディー． 胃保持型投与形態を調整する装置および方法
CA3007633A1 (en) 2015-12-08 2017-06-15 Lyndra, Inc. Geometric configurations for gastric residence systems
IL261756B2 (en) 2016-03-17 2023-11-01 Thiogenesis Therapeutics Inc Preparations for the controlled release of cysteamine and systemic treatment of disorders sensitive to cysteamine
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
AU2017268840B2 (en) 2016-05-27 2022-02-10 Lyndra Therapeutics, Inc. Materials architecture for gastric residence systems
MX2019000348A (es) * 2016-07-11 2019-03-28 Intec Pharma Ltd Formulaciones gastrorretentivas orales y usos de las mismas.
JP2019532947A (ja) 2016-09-30 2019-11-14 リンドラ，インコーポレイティド アダマンタン系薬物の持続的送達のための胃内滞留システム
WO2018102799A1 (en) 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system
KR20190107712A (ko) 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
JP7208982B2 (ja) 2017-09-20 2023-01-19 チオジェネシス セラピューティクス， インコーポレイテッド システアミン感受性障害の治療方法
JP7296084B2 (ja) 2017-12-04 2023-06-22 クレキシオ バイオサイエンシーズ エルティーディー． 長時間作用型胃滞留システム
WO2019137200A1 (en) 2018-01-09 2019-07-18 Triastek, Inc. Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
WO2019223753A1 (zh) 2018-05-23 2019-11-28 上海汉都医药科技有限公司 活性药物成分的控释系统及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
US10675248B2 (en) 2018-08-14 2020-06-09 Alma Therapeutics Ltd. Expandable pill
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574820A (en) 1968-01-08 1971-04-13 Upjohn Co Medicinal dosage forms of unpolymerized thiolated gelatin with a cross-linking accelerating agent providing slowly released medication from a swollen matrix
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4434153A (en) 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4735804A (en) 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
US5047464A (en) 1989-09-20 1991-09-10 Merck & Co., Inc. Bioerodible thermoset elastomers
US5217712A (en) 1989-09-20 1993-06-08 Merck & Co., Inc. Bioerodible thermoset elastomers
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
US6685962B2 (en) 2004-02-03
DE60021604D1 (de) 2005-09-01
EP1235557A2 (de) 2002-09-04
CA2392361C (en) 2010-01-19
DE60021604T2 (de) 2006-06-01
ATE300286T1 (de) 2005-08-15
WO2001037812A3 (en) 2002-02-21
CA2392361A1 (en) 2001-05-31
AU1647701A (en) 2001-06-04
AU783062B2 (en) 2005-09-22
ES2243327T3 (es) 2005-12-01
JP2003514845A (ja) 2003-04-22
ZA200204268B (en) 2003-08-28
US20030021845A1 (en) 2003-01-30
IL149853A (en) 2006-12-31
RU2002114348A (ru) 2004-01-10
WO2001037812A2 (en) 2001-05-31
JP4679020B2 (ja) 2011-04-27
EP1235557B1 (de) 2005-07-27

Similar Documents

Publication Publication Date Title
ZA200204268B (en) Gastroretentive controlled release pharmaceutical dosage forms.
Debotton et al. Applications of polymers as pharmaceutical excipients in solid oral dosage forms
US6632451B2 (en) Delayed total release two pulse gastrointestinal drug delivery system
EP1021171B1 (de) Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
US6531152B1 (en) Immediate release gastrointestinal drug delivery system
CA2446712C (en) System for osmotic delivery of pharmaceutically active agents
CA2014451A1 (en) Sustained-release oral drug dosage form
ZA912792B (en) Controlled release drug formulation
ATE477795T1 (de) Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
AU1488295A (en) Pharmaceutical composition
HRP20161433T1 (hr) Doprema lijeka zadržavanjem u želucu za karbidopa/levodopa
MD20020072A (en) Combination of antibiotic(s) - polymer and utilization there of
CA2272586A1 (en) Rapidly disintegrable pharmaceutical composition
MXPA02007254A (es) Forma de dosis de cubierta-y-nucleo que se aproxima a liberacion de droga de orden cero.
WO2003051304A3 (en) Bioadhesive drug delivery system with enhanced gastric retention
DE69729950D1 (de) System zur verzögerten freisetzung säurelabiler substanzen
AU2002303897A1 (en) System for osmotic delivery of pharmaceutically active agents
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
JPH0624959A (ja) 胃内浮遊型薬物徐放性固形製剤
CA2219777A1 (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
Park et al. Polymers in pharmaceutical products
Collette et al. Triblock Copolymers Self-Assembled in Vesicles: Applications to the Oral Delivery of Insulin
EP0375649A3 (de) Perorales quellungskontrolliertes System für die Übergabe von Arzneimitteln